PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

In two separate clinical studies, combined immunotherapy approach enhances cancer patient response

2024-06-20
(Press-News.org) Because not all cancer patients respond to a leading type of cancer immunotherapy drug, known as an immune checkpoint inhibitor, scientists explored whether adding janus kinase (JAK) inhibitors – drugs that treat chronic inflammation – could help. In two separate clinical studies, researchers found that adding JAK inhibitors did improve patients’ responses to cancer checkpoint inhibitor immunotherapies. “Aside from the exciting findings of the early phase trials reported by [both groups], they provide a great deal of data with complex analyses of immune responses,” write Massimo Gadina and John O’Shea in a related Perspective. “It will be exciting to see how such sophisticated data might be used in the clinic and to inform research.” Immune checkpoint inhibitors (ICIs) work by blocking checkpoint proteins on T cells that otherwise prevent the immune system from targeting and killing cancer cells. ICIs have substantially improved the treatment of some types of cancers. However, not all patients respond to these immunotherapies. And cancer patients often have chronic inflammation and immunosuppression, which can limit ICI treatment response.

 

In two independent clinical studies, researchers investigated whether using JAK inhibitors or jakinibs, which prevent inflammation from inside cells, could improve antitumor responses of anti-PD-1 ICI immunotherapy in cancer patients. Divij Mathew and colleagues conducted a phase II clinical trial to investigate the use of the JAK1 inhibitor itacitinib in combination with the anti-PD-1 ICI pembrolizumab as a first-line treatment for metastatic non-small cell lung cancer (NSCLC). Mathew et al. found that delayed administration of itacitinib following treatment of pembrolizumab improved the response of immunotherapy. According to the findings of the trial, which included 21 patients with treatment-naïve NSCLC, median progression-free survival was nearly 2 years, compared to the 6.5 to 10.3 months reported in other trials with only ICI. In a separate study, Jaroslav Zak and colleagues report results from a phase I/II clinical trial in patients with relapsing-refractory Hodgkin lymphoma who had previously received ICI and were unresponsive or showed mixed response. Zak et al. focused on the use of a combination of ruxolitinib, a JAK1 and JAK2 inhibitor, and the anti-PD-1 drug nivolumab. According to the findings, administration of ruxolitinib 8 days before the start of nivolumab therapy resulted in improved clinical efficacy in patients that had previously failed ICI immunotherapy. Among the 19 patients who participated, overall survival was 87% at 2 years compared to previous reports of 23.8% with ICI alone.

 

Science Senior Editor, Priscilla Kelly, commented: “These two clinical trials are notable because they pave the way for a new possible therapeutic strategy. The researchers find that in two different cancer types, combining Janus kinase (JAK) inhibitors with checkpoint inhibitor immunotherapy results in better clinical responses in patients with metastatic non-small cell lung cancer and those with relapsed or refractory Hodgkin lymphoma. In the study involving patients with metastatic non-small cell lung cancer, this combination therapy was delivered as a first-line treatment.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Airborne mapping reveals roles for biogenic sources and temperature in air pollution emissions in Los Angeles

2024-06-20
Airborne observations over California have revealed that biogenic sources of volatile organic compounds (VOCs) – blooming trees and growing plants – dominate summertime air pollutant formation in Los Angeles, in a way that increases with temperature. Future air pollution regulations thus need to consider that only 40% of urban VOC emissions (those not tied to biogenic sources) can be mitigated through regulations, say the authors. Ambient air pollution – the fourth-leading global ...

Old bombs reveal new insights: Plants store more carbon, but for a shorter time frame, than we thought

2024-06-20
Analysis of radiocarbon produced during nuclear bomb testing in the 1960s suggests that current Earth system models underestimate carbon uptake into terrestrial vegetation and soils. But, say the study’s authors, this storage is more short-lived than previously thought. The findings suggest that anthropogenic carbon dioxide will not reside as long in the terrestrial biosphere as models currently predict. Accurate climate predictions, crucial for developing effective climate policies, require a robust representation of the global carbon cycle. It’s thought that vegetation and soils account for taking up approximately 30% of anthropogenic carbon dioxide (CO2) ...

The time it takes a person to decide can predict their preference

The time it takes a person to decide can predict their preference
2024-06-20
Researchers led by Sophie Bavard at the University of Hamburg, Germany, found that people can infer hidden social preferences by observing how fast others make social decisions. Publishing June 20th in the open-access journal PLOS Biology, the study shows that when someone knows the options being considered by another person, and they know how long it takes them to reach their decisions, they can use this information to predict the other person’s preference, even if they do not know what the actual choices were. How do we know what someone’s social preferences ...

Hurricane changed ‘rules of the game’ in monkey society

Hurricane changed ‘rules of the game’ in monkey society
2024-06-20
A devastating hurricane transformed a monkey society by changing the pros and cons of interacting with others, new research shows. Hurricane Maria hit Puerto Rico in 2017, killing more than 3,000 people. It also destroyed 63% of vegetation on Cayo Santiago (also known as Monkey Island), which is home to a population of rhesus macaques. Even now, tree cover remains far below pre-hurricane levels and – in this hot part of the world – that makes shade a scarce and precious resource for the macaques. The new study, led by the universities of Pennsylvania and Exeter and published in the journal Science, shows the storm ...

Researchers widely observe yet seldom publish about same-sex sexual behavior in primates and other mammals - often because it is perceived to be rare

Researchers widely observe yet seldom publish about same-sex sexual behavior in primates and other mammals - often because it is perceived to be rare
2024-06-20
Researchers widely observe yet seldom publish about same-sex sexual behavior in primates and other mammals - often because it is perceived to be rare ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0304885 Article Title: Same-sex sexual behaviour among mammals is widely observed, yet seldomly reported: Evidence from an online expert survey Author Countries: Canada, USA Funding: The authors received no specific funding for this work. END ...

Wild chimpanzees seek out medicinal plants to treat illness and injuries

Wild chimpanzees seek out medicinal plants to treat illness and injuries
2024-06-20
Chimpanzees appear to consume plants with medicinal properties to treat their ailments, according to a study publishing on June 20 in the open-access journal PLOS ONE by Elodie Freymann from the University of Oxford, UK, and colleagues. Many plants produce compounds that have medicinal effects on humans and other animals. Wild chimpanzees eat a variety of plant matter, including some that is nutritionally poor but may treat or lessen the symptoms of illness. However, it is hard to determine whether chimpanzees self-medicate, by intentionally seeking out plants with properties that help their specific ailments, or passively consume plants ...

New catalyst unveils the hidden power of water for green hydrogen generation

New catalyst unveils the hidden power of water for green hydrogen generation
2024-06-20
Hydrogen is a promising chemical and energy vector to decarbonize our society. Unlike conventional fuels, hydrogen utilization as a fuel does not generate carbon dioxide in return. Unfortunately, today, most of the hydrogen that is produced in our society comes from methane, a fossil fuel. It does so in a process (methane reforming) that leads to substantial carbon dioxide emissions. Therefore, the production of green hydrogen requires scalable alternatives to this process. Water electrolysis offers a path to generate green hydrogen which can be ...

Supermassive black hole appears to grow like a baby star

Supermassive black hole appears to grow like a baby star
2024-06-20
Supermassive black holes pose unanswered questions for astronomers around the world, not least “How do they grow so big?” Now, an international team of astronomers, including researchers from Chalmers University of Technology in Sweden, has discovered a powerful rotating, magnetic wind that they believe is helping a galaxy’s central supermassive black hole to grow. The swirling wind, revealed with the help of the ALMA telescope in nearby galaxy ESO320-G030, suggests that similar processes are involved both in black hole growth and the birth of stars.   Most galaxies, including our own Milky Way have a supermassive black hole at their centre. How ...

Early detection crucial in bile duct cancer for patients with rare liver disease

Early detection crucial in bile duct cancer for patients with rare liver disease
2024-06-20
Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma (CCA). This cancer is aggressive, and curative surgery is uncommon. Liver transplantation is a potential treatment option for some PSC-CCA patients, especially if the cancer is caught early. Early diagnosis is essential for successful treatment. PSC can affect people of all ages but primarily strikes men in their 30s and 40s. It is often accompanied by inflammatory bowel disease (IBD). The disease can progress to liver failure and increase the risk of colorectal cancer ...

BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy

BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy
2024-06-20
This study is led by Professor Junnian Zheng and Ming Shi from the Cancer Institute of Xuzhou Medical University, together with the team of Professor Guiyun Cui and Wei Zhang from the Affiliated Hospital of Xuzhou Medical University. The team reported for the first time using BCMA-CD19 bispecific CAR T cells for treating relapsed/refractory CIDP.   Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an uncommon condition with sudden onset symptoms, including nerve damage affecting movement, sensation, speech, breathing, and heart rate. ...

LAST 30 PRESS RELEASES:

Milky Way-like galaxy M83 consumes high-speed clouds

Study: What we learned from record-breaking 2021 heat wave and what we can expect in the future

Transforming treatment outcomes for people with OCD

Damage from smoke and respiratory viruses mitigated in mice via a common signaling pathway

New software tool could help better understand childhood cancer

Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility

Women 65+ still at heightened risk of cervical cancer caused by HPV

‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk

Effective therapies needed to halt rise in eco-anxiety, says psychology professor

Nature-friendly farming boosts biodiversity and yields but may require new subsidies

Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals

Microplastics discovered in human reproductive fluids, new study reveals

Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa

Novel flu vaccine adjuvant improves protection against influenza viruses, study finds

Manipulation of light at the nanoscale helps advance biosensing

New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance

New study links blood metabolites and immune cells to increased risk of urolithiasis

Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2

New insights into the clinical impact of IKBKG mutations: Understanding the mechanisms behind rare immunodeficiency syndromes

Displays, imaging and sensing: New blue fluorophore breaks efficiency records in both solids and solutions

Sugar, the hidden thermostat in plants

Personality can explain why some CEOs earn higher salaries

This puzzle game shows kids how they’re smarter than AI

Study suggests remembrances of dead played role in rise of architecture in Andean region

Brain stimulation can boost math learning in people with weaker neural connections

Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds

Neurotechnology reverses biological disadvantage in maths learning

UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning

Scientists target ‘molecular machine’ in the war against antimicrobial resistance

Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting

[Press-News.org] In two separate clinical studies, combined immunotherapy approach enhances cancer patient response